PCM
MBOT icon

Poehling Capital Management’s Microbot Medical MBOT Stock Holding History

Poehling Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1
Closed – – 199
2018
Q2 		$0 Buy
+1
New +$12 ﹤0.01% 317
2018
Q1 		– Sell
-1
Closed – – 326
2017
Q4 		$0 Buy
+1
New +$17 ﹤0.01% 291

Other funds holding MBOT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Poehling Capital Management's MBOT Position: Q3 2018 in Review

Poehling Capital Management sold out of Microbot Medical (MBOT) in Q3 2018, closing a stake of 1 share.

Poehling Capital Management first reported a position in MBOT in Q4 2017 and held it in 2 quarters. The position peaked at $0 in Q2 2018. 29 funds tracked by Wall St. Rank hold MBOT as of Q3 2018.

  • Poehling Capital Management reported no remaining Microbot Medical position as of Q3 2018 after selling out during the quarter.
  • Poehling Capital Management sold 1 Microbot Medical share in Q3 2018.
  • Poehling Capital Management first reported a position in Microbot Medical in Q4 2017 and held it in 2 quarters.
  • Poehling Capital Management's Microbot Medical position peaked at $0 in Q2 2018.
  • 29 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2018.

Based on Poehling Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.